By: Jeremy Katz
In the ever-evolving landscape of medicine and pharmaceuticals, only a handful of products ever rise to the status of becoming true game-changers. Vitastem Ultra, an extraordinary topical antibiotic, is proving to be one such medication, making significant waves in the healthcare industry as a formidable force in infection prevention and advanced wound care. This FDA-registered topical antibiotic spray has been steadfastly battling minor to severe wounds and infections for over a decade, setting new benchmarks in the realm of wound care and infection prevention.
According to recent company news, the ViaDerma management team has been collaborating with their new contract product manufacturer to bolster production capabilities to support large volume orders. This expansion is geared towards accommodating the surge in demand, with orders ranging from 250,000 to 300,000 units per country in the pipeline for this year.
With stability testing for Vitastem Ultra nearing its completion, ViaDerma (OTC: VDRM) is poised to meet the rising demand in the Caribbean, Middle East, Egypt, and India. The discussions with sales partners indicate initial distribution targets of 300,000 units per country annually, with plans for further scaling as the product gains traction.
What distinguishes Vitastem Ultra is its remarkable track record, boasting an astonishing 10-fold increase in effectiveness when compared to its counterparts in the field of wound care and infection prevention. Crafted by the innovative minds at ViaDerma, this product, now readily available over the counter (OTC), serves as a versatile solution for a wide spectrum of conditions. From acne and cuts and scrapes to diabetic ulcers, eczema, psoriasis, lacerations, scars, shingles, staph, MRSA, and a range of other minor to severe wounds, Vitastem Ultra has proven its mettle.
Notably, Vitastem Ultra is the only antibiotic in the world that employs both physical and chemical mechanisms to combat infections, endowing it with a unique ability to defeat drug-resistant bacteria. This distinctive feature, coupled with its capacity to heal and regenerate tissue, sets it apart from any other medication available on the market.
To date, Vitastem Ultra has achieved remarkable results, with 96% of patients with diabetic wounds and ulcers experiencing significant improvements within just two weeks, overshadowing its largest name-brand prescription competitor, where only 50% of patients see improvements after 20 weeks. Vitastem Ultra has been a lifeline for countless patients, averting amputations, reducing hospital stays, and enhancing life expectancy.
The key to Vitastem Ultra’s efficacy lies in its exclusive formulation, enabling it to target a broad spectrum of bacteria and pathogens. This makes it the preferred choice for healthcare facilities, hospitals, nursing homes, and other care facilities committed to curbing the surge of healthcare-associated infections (HAIs) and the ascent of formidable superbugs like MRSA.
Vitastem Ultra’s appeal extends beyond its effectiveness. Its user-friendly application as a topical antibiotic spray makes it a convenient and accessible choice for individuals seeking immediate relief from wounds and infections. Furthermore, its OTC availability aligns with the evolving dynamics of the healthcare industry, reducing the need for prescription antibiotics in certain cases.
As the demand for this novel and innovative wound treatment continues to escalate, ViaDerma is actively expanding its distribution network to cater to this growing need. Recent announcements indicate a strategic push into healthcare providers across regions like the Caribbean, the Middle East, Egypt, and India, where the demand for groundbreaking antibiotics is soaring.
This expansion couldn’t have come at a more critical juncture, as healthcare professionals worldwide grapple with the escalating threat of antibiotic-resistant bacterial infections. Vitastem Ultra’s presence in these regions promises to play a pivotal role in the fight against infectious diseases, ensuring that patients gain access to cutting-edge infection prevention and wound care.
In a world where antibiotic resistance poses an escalating threat to public health, Vitastem Ultra stands as a beacon of hope for healthcare providers and their patients. It not only equips healthcare providers with a potent tool for their arsenal but also offers an accessible solution for individuals in search of effective wound care and infection prevention.
As the demand for groundbreaking antibiotics like Vitastem Ultra continues to surge, it is evident that this exceptional product is here to stay and will undeniably reshape the future of medicine and patient care. ViaDerma’s global expansion is a testament to the transformative impact Vitastem Ultra’s topical antibiotic is poised to make on the world stage.
